Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,034
Closed -$458K 132
2024
Q3
$458K Sell
4,034
-381
-9% -$45.3K 0.15% 95
2024
Q2
$547K Sell
4,415
-408
-8% -$52.6K 0.2% 87
2024
Q1
$636K Sell
4,823
-1,309
-21% -$161K 0.25% 81
2023
Q4
$669K Sell
6,132
-2,048
-25% -$213K 0.29% 66
2023
Q3
$842K Sell
8,180
-3,105
-28% -$335K 0.42% 53
2023
Q2
$1.3M Sell
11,285
-2,683
-19% -$305K 0.58% 46
2023
Q1
$1.49M Sell
13,968
-439
-3% -$47.4K 0.67% 42
2022
Q4
$1.6M Sell
14,407
-281
-2% -$28.7K 0.73% 41
2022
Q3
$1.26M Buy
14,688
+884
+6% +$78.9K 0.78% 35
2022
Q2
$1.26M Buy
13,804
+310
+2% +$27.5K 0.71% 36
2022
Q1
$1.11M Buy
+13,494
New +$1.06M 0.56% 51
2021
Q1
Sell
-2,571
Closed -$201K 149
2020
Q4
$201K Hold
2,571
0.12% 130
2020
Q3
$203K Buy
+2,571
New +$201K 0.15% 103
2020
Q1
Sell
-2,847
Closed -$247K 112
2019
Q4
$247K Sell
2,847
-1,253
-31% -$103K 0.19% 89
2019
Q3
$329K Hold
4,100
0.24% 71
2019
Q2
$328K Buy
4,100
+95
+2% +$7.27K 0.27% 74
2019
Q1
$318K Hold
4,005
0.27% 74
2018
Q4
$292K Sell
4,005
-122
-3% -$8.61K 0.26% 71
2018
Q3
$279K Sell
4,127
-121
-3% -$7.71K 0.23% 81
2018
Q2
$246K Buy
4,248
+109
+3% +$6.15K 0.21% 85
2018
Q1
$215K Hold
4,139
0.2% 82
2017
Q4
$222K Buy
+4,139
New +$229K 0.2% 79

Other funds holding MRK

Weil Company's MRK Position: Q4 2024 in Review

Weil Company sold out of Merck (MRK) in Q4 2024, closing a stake of 4,034 shares — an estimated $458K sold.

Weil Company first reported a position in MRK in Q4 2017 and held it in 22 quarters. The position peaked at $1.6M in Q4 2022. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Weil Company reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Weil Company sold 4,034 Merck shares in Q4 2024, an estimated $458K.
  • Weil Company first reported a position in Merck in Q4 2017 and held it in 22 quarters.
  • Weil Company's Merck position peaked at $1.6M in Q4 2022.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Weil Company's 13F filing for Q4 2024, filed 5 Feb 2025.